Healthcare Hedge Fund Just Invested $24.5M in Immunovant
A healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...
Identify key moments to de-risk in retirement, using timing signals to reduce exposure while preserving income.
27,016 articlesA healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...
Cathie Wood's bold bets launched a new era for ETFs. This piece explains how ARK helped fuel demand for active ETFs, ...
Boxer Capital quietly boosted its stake in Corvus Pharmaceuticals, a move that signals institutional faith in the bio...
Snowflake stock soaring has investors buzzing. This guide explains what's driving the rally, how to value the stock, ...
A fresh investing approach blends emerging-market debt with high-quality short bonds to deliver higher income and ste...
Investing in niche AI infrastructure can offer outsized upside, but only with a plan. This article shows how buying P...
JPMorgan says it has built an AI agent to gauge markets and economics with the aim of outperforming the standard 60/4...
A notable stake change in Victoria’s Secret & Co. raises questions for investors. This article explains what the capi...
Two popular short-term bond ETFs—VCSH and ISTB—offer different paths to steady income. This guide breaks down cost, r...
The crypto market has questions about XRP at sub-$1.50 levels. This guide weighs the risks and potential rewards, off...
Bitcoin's renewed drop pulled Strategy, BitMine, and Robinhood shares toward monthly lows. This article breaks down w...
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...